Daniel S. Lynch ’80 was named chief executive officer and director of ImClone Systems, Inc., a biopharmaceutical company. He had joined ImClone in April 2001 as vice president of finance and chief financial officer, and he had been serving as the senior vice president and chief administrative officer and acting CEO since April 2003. The chairman of the board noted, “Dan’s stewardship of ImClone Systems during one of its most critical and challenging periods has been exemplary,” and cited his leadership qualities, management skills, and his experience in finance and the international pharmaceuticals business. Lynch majored in mathematics at Wesleyan and earned a master’s in business administration from the Darden Graduate School of Business.
